# Surgical Science Sweden > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/surgicalsciencesweden). ## Overview Surgical Science Sweden AB develops medical simulation solutions used to train surgeons and other healthcare professionals in minimally invasive procedures. The company is headquartered in Gothenburg, Sweden, and operates through an international footprint with offices and sales presence in the US, the UK, China, Israel, and Sweden. ## Products & services • Surgical simulation software and training platforms • Laparoscopic and endoscopic procedure simulators • Robotic surgery simulation solutions • Ultrasound simulation products • Training, support, and implementation services - **Surgical simulation software** (40%) — Digital simulation platforms used to train clinicians in surgical techniques and workflows. - **Hardware-based simulators** (30%) — Physical simulator systems and devices used for hands-on procedural training. - **Robotics training solutions** (20%) — Simulation tools focused on robotic-assisted surgery training and certification. - **Ultrasound simulation** (10%) — Simulation products for ultrasound education and clinical skills development. - Surgical simulation software and training platforms - Laparoscopic and endoscopic procedure simulators - Robotic surgery simulation solutions - Ultrasound simulation products - Training, support, and implementation services ## Customers Customers are primarily hospitals, medical schools, training centers, and healthcare organizations that need objective, repeatable surgical training. The company also sells to OEMs and technology partners in the surgical robotics ecosystem, where simulation is used for product training, adoption, and certification. Demand is driven by the need for safer training, standardized credentialing, and broader use of simulation in clinical education. - **Hospitals and health systems** (primary) — Buy simulators and training platforms to train surgeons and staff before procedures. - **Medical schools and simulation centers** (primary) — Purchase simulation systems for education, skills practice, and curriculum support. - **Surgical robotics OEMs** (primary) — Use simulation products to support training, onboarding, and certification around robotic systems. - **Healthcare training organizations** (secondary) — Acquire software and services for standardized procedural training and assessment. - **Ultrasound education users** (secondary) — Buy ultrasound simulation tools for clinical skills development and training programs. - Hospitals and health systems training surgeons and staff - Medical schools and simulation centers - Surgical robotics OEMs needing training tools - Healthcare educators seeking standardized certification - Distributors and partners supporting regional deployment ## Geography Surgical Science is headquartered in Sweden but operates internationally through offices in the US, the UK, China, and Israel. The company’s operating footprint matters because sales, support, and implementation are closely tied to local healthcare customers and training institutions. Its revenue and cost base are exposed to several currencies, especially USD, ILS, EUR, and GBP. - **Sweden** (3%) — Estimated from headquarters and operating presence - **United States** (45%) — Major commercial and support market - **United Kingdom** (10%) — Regional sales and support office - **Israel** (15%) — Important operating location and currency exposure - **China** (7%) — Sales office serving China and broader Asia - **Other Europe** (20%) — Estimated remainder of international business - Headquartered in Gothenburg, Sweden - Major operating presence in the United States - Sales office in China supports Asia-Pacific activity - UK office serves European customers and partners - Israel is a key operating location and cost base ## Strategy Surgical Science’s strategy centers on making simulation a standard part of healthcare training and certification. The company is focused on organic growth, selective acquisitions, and building a stronger position across its core market segments, while expanding its commercial footprint in key regions. The strategy also emphasizes disciplined execution, targeted investment in expertise, and broader adoption of simulation in robotics and other surgical workflows. - **Broaden adoption of simulation in healthcare** (long-term) — Higher penetration supports long-term demand for training platforms and recurring customer relationships. - **Expand in robotics and ultrasound training** (medium-term) — These areas connect the company to fast-evolving surgical workflows and OEM ecosystems. - **Use acquisitions to accelerate scale** (medium-term) — Acquisitions can add products, customers, and geographic reach faster than organic growth alone. - **Build local commercial presence** (short-term) — Simulation sales and support are relationship-driven and often require local implementation capability. - Expand simulation use in healthcare training and certification - Grow in five core market segments with low penetration - Use acquisitions to add products and scale - Strengthen commercial presence in the US and UK - Invest in expertise, capacity, and product breadth ## Risks The business depends on long sales cycles, customer adoption of simulation, and continued demand from healthcare institutions and OEM partners. It is also exposed to currency swings, tariff-related costs, integration risk from acquisitions, and concentration risk around large customers and key markets. As a medical training company, it faces industry risks tied to regulation, procurement cycles, and the pace at which healthcare systems adopt simulation-based training. - **Long sales cycles** [high] — Orders can take months to close, delaying revenue recognition and cash conversion. - **Customer concentration** [high] — A large customer or partner can materially affect demand if purchasing patterns change. - **Foreign exchange volatility** [medium] — Revenue and costs are spread across USD, ILS, EUR, and GBP, creating translation and transaction risk. - **Tariff and trade cost pressure** [medium] — US-bound simulator sales are directly affected by tariffs and import-related costs. - **Acquisition integration** [medium] — Integrating acquired businesses can affect systems, product roadmaps, and operating execution. - Long sales cycles delay revenue conversion - Customer concentration can create volatility - FX exposure affects revenue and cost translation - Tariffs can raise US import and delivery costs - Acquisition integration can disrupt execution ## Accounting Revenue recognition can be judgmental because the company sells a mix of software, hardware, and services that may be delivered at different times. Investors should also watch acquisition accounting, goodwill, and intangible asset valuation, since the business has grown through purchases and these assets can be sensitive to assumptions. Foreign currency translation, lease accounting, and share-based incentive costs also affect reported results and comparability across periods. - **Revenue recognition across product and service bundles** — Software, hardware, and support contracts may be recognized at different times - **Goodwill and acquired intangibles** — Future write-downs could affect reported earnings and equity - **Foreign currency translation** — USD, ILS, EUR, and GBP exposure affects revenue and cost comparability - **Share-based payment accounting** — Non-cash compensation affects operating profit and dilution - **Lease accounting** — Office footprint affects balance sheet and depreciation/interest expense - Mixed software, hardware, and service revenue affects timing of recognition - Acquisition accounting creates goodwill and intangible asset balances - Goodwill impairment risk depends on future cash flow assumptions - FX translation affects reported revenue and costs across currencies - IFRS 2 incentive costs affect operating expenses and dilution --- *Last updated: 2026-08-11T04:04:56.060637+00:00*